Cofactor Genomics is a biotechnology company that leverages RNA-expression models to bring precision medicine to immunotherapy. The company develops predictive diagnostics that characterize the microenvironment of a tumor and predict patient response to immunotherapy. Cofactor Genomics was founded following the Human Genome Project and focuses on creating multidimensional biomarkers to better match patients to therapies. The company is involved in the PREDAPT Trial, which evaluates the use of its OncoPrism assay to predict responses to immunotherapy across various solid tumor cancers
Cofactor Genomics Valuation History
Cofactor Genomics Stock Price
The stock price of Cofactor Genomics can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
For illustrative purposes, however, assuming Cofactor Genomics has issued 250 million shares, at the estimated UpMarket valuation of $32.94 million, each share of Cofactor Genomics stock would be worth $0.13.
Buy Cofactor Genomics Stock
If you would like to buy shares in Cofactor Genomics, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss Cofactor Genomics stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, Cofactor Genomics as well.
UpMarket's mission is to unlock the private markets for individual investors.
We provide access to a range of asset classes and investment strategies that span private equity, hedge funds, crypto, real estate, and other alternative assets.
The problem
Historically, accessing private market investments had these challenges:
A large barrier to entry due to high investment minimums
Time-intensive because sourcing deals is a lot of work even if you’ve got a great network, and
Costly because of investment-related diligence costs, paperwork, and legal fees
The solution
UpMarket works to address these barriers for individual investors by:
Offering lower investment minimums
Sourcing and conducting diligence on opportunities for investors, empowering them to pick and choose from pre-screened opportunities
Making the investment process entirely digital, straightforward, and easy to manage from a single portal
Individuals like you have invested over $150 Million with UpMarket.
UpMarket Investment Curation Process
Upmarket curates and conducts diligence on every investment opportunity we offer.
We review every offering’s strategy, risk management, liquidity management, fees and expenses, valuation methodology, tax matters, as well as the fund’s third-party providers including legal counsel, auditor, administrator, and custodian.
We aim to offer our clients investments from disciplined managers that pursue unique strategies across an array of asset classes.
Our goal is to empower you to build a portfolio that best meets your individual Investment objectives.
Unlock the private markets today, with UpMarket.
Success!
Thank you for your submission.
A professional from our Investor Relations team will be in touch shortly.
